InvestorsHub Logo
Followers 80
Posts 24704
Boards Moderated 1
Alias Born 09/08/2000

Re: None

Friday, 09/21/2018 7:23:40 AM

Friday, September 21, 2018 7:23:40 AM

Post# of 27623
APDN - 1.39 Pre-market now at 1.57/1.66

Applied DNA Subsidiary, LineaRx, Inc. Signs Joint Development Agreement with Takis and Evvivax to Develop Linear-DNA Based Anti-Cancer Vaccines

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.